Security key
92337R101
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.001 per share
- Shares outstanding
- 72,325,000
- Total 13F shares
- 62,915,975
- Share change
- -61,349
- Total reported value
- $1,512,522,250
- Put/Call ratio
- 27%
- Price per share
- $24.02
- Number of holders
- 176
- Value change
- -$90,036,678
- Number of buys
- 101
- Number of sells
- 79
Report period
Q1 2025
Institutions
176
Top holders
10
VERA full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92337R101
Recent filing periods:
Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
13D/G
|
Company |
8.9%
from 13D/G
|
5,610,000
|
$237,246,900 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.1%
|
4,377,049
|
$185,107,000 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.4%
|
3,941,486
|
$166,685,443 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
4.2%
|
3,053,126
|
$129,116,698 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
2,949,564
|
$124,737,062 | — | 31 Dec 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3.9%
|
2,793,987
|
$118,157,710 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
2,026,352
|
$85,694,426 | — | 31 Dec 2024 | |
| Commodore Capital LP |
13F
3/4/5
|
Company · 10%+ Owner |
2.7%
|
1,958,600
|
$82,829,194 | — | 31 Dec 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
2.6%
|
1,875,963
|
$79,334,475 | — | 31 Dec 2024 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
2.3%
|
1,662,220
|
$70,295,283 | — | 31 Dec 2024 | |
| Eversept Partners, LP |
13F
|
Company |
2.2%
|
1,600,015
|
$67,664,634 | — | 31 Dec 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
2%
|
1,457,910
|
$61,655,014 | — | 31 Dec 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2%
|
1,437,339
|
$60,785,066 | — | 31 Dec 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2%
|
1,415,179
|
$59,848,000 | — | 31 Dec 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.7%
|
1,261,246
|
$53,338,093 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.7%
|
1,202,466
|
$50,852,287 | — | 31 Dec 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.6%
|
1,153,670
|
$48,788,000 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,153,325
|
$48,787,008 | — | 31 Dec 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.6%
|
1,150,000
|
$48,633,500 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.5%
|
1,085,986
|
$45,926,348 | — | 31 Dec 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.5%
|
1,075,000
|
$45,461,750 | — | 31 Dec 2024 | |
| Logos Global Management LP |
13F
|
Company |
1.2%
|
875,000
|
$37,003,750 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
841,313
|
$35,579,127 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.2%
|
837,146
|
$35,402,906 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.1%
|
813,861
|
$34,418,182 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
810,376
|
$34,270,802 | — | 31 Dec 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
1%
|
758,465
|
$32,075,485 | — | 31 Dec 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
742,572
|
$31,403,370 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.96%
|
695,091
|
$29,395,398 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.77%
|
554,729
|
$23,459,489 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.67%
|
487,863
|
$20,631,726 | — | 31 Dec 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.67%
|
485,145
|
$20,405,199 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.66%
|
480,000
|
$20,299,200 | — | 31 Dec 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.64%
|
464,807
|
$19,656,688 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
455,007
|
$19,242,246 | — | 31 Dec 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.6%
|
432,000
|
$18,269,280 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
430,665
|
$18,212,823 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.59%
|
428,940
|
$18,139,936 | — | 31 Dec 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.59%
|
425,000
|
$17,973,250 | — | 31 Dec 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.53%
|
385,425
|
$16,299,623 | — | 31 Dec 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.51%
|
365,999
|
$15,478,098 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.45%
|
328,515
|
$13,892,900 | — | 31 Dec 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.36%
|
257,788
|
$10,901,855 | — | 31 Dec 2024 | |
| AXA S.A. |
13F
|
Company |
0.34%
|
245,879
|
$10,398,223 | — | 31 Dec 2024 | |
| Alphabet Inc. |
13F
|
Company |
0.33%
|
241,264
|
$10,203,056 | — | 31 Dec 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.33%
|
235,267
|
$9,949,441 | — | 31 Dec 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.32%
|
230,558
|
$9,750,298 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.31%
|
221,485
|
$9,366,600 | — | 31 Dec 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.29%
|
212,696
|
$8,994,914 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.27%
|
194,027
|
$8,205,414 | — | 31 Dec 2024 |
Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q1 2025
As of 31 Mar 2025,
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,915,975 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, Sofinnova Investments, Inc., COMMODORE CAPITAL LP, Vestal Point Capital, LP, Kynam Capital Management, LP, and Holocene Advisors, LP.
This page lists
177
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
177
Q1 2025 holders
176
Holder diff
-1
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.